CVE-2017-9063

Description

In WordPress before 4.7.5, a cross-site scripting (XSS) vulnerability related to the Customizer exists, involving an invalid customization session.

Category

6.1
CVSS
Severity: Medium
CVSS 3.0 •
CVSS 2.0 •
EPSS 1.54% Top 20%
Vendor Advisory debian.org Vendor Advisory wordpress.org Vendor Advisory wordpress.org
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.securitytracker.com/id/1038520 third party advisory vdb entry
https://wordpress.org/news/2017/05/wordpress-4-7-5/ patch vendor advisory
http://www.debian.org/security/2017/dsa-3870 third party advisory vendor advisory
http://www.securityfocus.com/bid/98509 third party advisory vdb entry
https://wpvulndb.com/vulnerabilities/8820 third party advisory patch
https://github.com/WordPress/WordPress/commit/3d10fef22d788f29aed745b0f5ff6f6baea69af3 third party advisory patch
https://codex.wordpress.org/Version_4.7.5 patch vendor advisory release notes

Frequently Asked Questions

What is the severity of CVE-2017-9063?
CVE-2017-9063 has been scored as a medium severity vulnerability.
How to fix CVE-2017-9063?
To fix CVE-2017-9063, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-9063 being actively exploited in the wild?
It is possible that CVE-2017-9063 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~2% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.